nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—melanoma	0.223	1	CbGaD
Alitretinoin—CYP1A2—Carmustine—melanoma	0.083	0.323	CbGbCtD
Alitretinoin—CYP1A2—Vemurafenib—melanoma	0.0656	0.256	CbGbCtD
Alitretinoin—CYP1A2—Dacarbazine—melanoma	0.0503	0.196	CbGbCtD
Alitretinoin—ABCB1—Dactinomycin—melanoma	0.0381	0.148	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—melanoma	0.0197	0.0767	CbGbCtD
Alitretinoin—CRABP2—skin epidermis—melanoma	0.00989	0.132	CbGeAlD
Alitretinoin—CRABP1—neck—melanoma	0.00524	0.0699	CbGeAlD
Alitretinoin—RXRG—neck—melanoma	0.00414	0.0552	CbGeAlD
Alitretinoin—CRABP1—eye—melanoma	0.0039	0.052	CbGeAlD
Alitretinoin—CRABP1—retina—melanoma	0.00386	0.0515	CbGeAlD
Alitretinoin—CRABP2—eye—melanoma	0.00352	0.047	CbGeAlD
Alitretinoin—CRABP1—skin of body—melanoma	0.00339	0.0452	CbGeAlD
Alitretinoin—CRABP1—mammalian vulva—melanoma	0.00309	0.0412	CbGeAlD
Alitretinoin—RXRG—eye—melanoma	0.00308	0.0411	CbGeAlD
Alitretinoin—CRABP2—skin of body—melanoma	0.00306	0.0409	CbGeAlD
Alitretinoin—CRABP2—mammalian vulva—melanoma	0.0028	0.0373	CbGeAlD
Alitretinoin—RARG—eye—melanoma	0.00257	0.0343	CbGeAlD
Alitretinoin—RARG—retina—melanoma	0.00255	0.034	CbGeAlD
Alitretinoin—RARG—skin of body—melanoma	0.00224	0.0298	CbGeAlD
Alitretinoin—CRABP1—head—melanoma	0.00221	0.0295	CbGeAlD
Alitretinoin—RARG—mammalian vulva—melanoma	0.00204	0.0272	CbGeAlD
Alitretinoin—CRABP2—head—melanoma	0.002	0.0267	CbGeAlD
Alitretinoin—RXRA—head—melanoma	0.00199	0.0266	CbGeAlD
Alitretinoin—RARB—head—melanoma	0.00179	0.0239	CbGeAlD
Alitretinoin—RXRG—head—melanoma	0.00175	0.0233	CbGeAlD
Alitretinoin—RXRB—head—melanoma	0.00164	0.0219	CbGeAlD
Alitretinoin—RARG—head—melanoma	0.00146	0.0195	CbGeAlD
Alitretinoin—RARA—head—melanoma	0.00137	0.0183	CbGeAlD
Alitretinoin—RARB—lymph node—melanoma	0.00125	0.0167	CbGeAlD
Alitretinoin—RARG—lymph node—melanoma	0.00102	0.0136	CbGeAlD
Alitretinoin—RARA—lymph node—melanoma	0.00096	0.0128	CbGeAlD
Alitretinoin—ABCB1—blood vessel—melanoma	0.000863	0.0115	CbGeAlD
Alitretinoin—ABCB1—retina—melanoma	0.000455	0.00607	CbGeAlD
Alitretinoin—ABCB1—mammalian vulva—melanoma	0.000364	0.00486	CbGeAlD
Alitretinoin—Eye disorder—Temozolomide—melanoma	0.000275	0.00107	CcSEcCtD
Alitretinoin—Tinnitus—Temozolomide—melanoma	0.000275	0.00107	CcSEcCtD
Alitretinoin—Malaise—Bleomycin—melanoma	0.000274	0.00107	CcSEcCtD
Alitretinoin—Flushing—Temozolomide—melanoma	0.000273	0.00106	CcSEcCtD
Alitretinoin—Arrhythmia—Carmustine—melanoma	0.000272	0.00106	CcSEcCtD
Alitretinoin—Dizziness—Vemurafenib—melanoma	0.000271	0.00105	CcSEcCtD
Alitretinoin—Alopecia—Carmustine—melanoma	0.000269	0.00105	CcSEcCtD
Alitretinoin—Angiopathy—Temozolomide—melanoma	0.000267	0.00104	CcSEcCtD
Alitretinoin—Mental disorder—Carmustine—melanoma	0.000267	0.00104	CcSEcCtD
Alitretinoin—Malnutrition—Carmustine—melanoma	0.000265	0.00103	CcSEcCtD
Alitretinoin—Erythema—Carmustine—melanoma	0.000265	0.00103	CcSEcCtD
Alitretinoin—Cough—Bleomycin—melanoma	0.000265	0.00103	CcSEcCtD
Alitretinoin—Chills—Temozolomide—melanoma	0.000264	0.00103	CcSEcCtD
Alitretinoin—Dehydration—Docetaxel—melanoma	0.000263	0.00102	CcSEcCtD
Alitretinoin—Ill-defined disorder—Dactinomycin—melanoma	0.000263	0.00102	CcSEcCtD
Alitretinoin—Anaemia—Dactinomycin—melanoma	0.000262	0.00102	CcSEcCtD
Alitretinoin—ABCB1—head—melanoma	0.000261	0.00348	CbGeAlD
Alitretinoin—Vomiting—Vemurafenib—melanoma	0.00026	0.00101	CcSEcCtD
Alitretinoin—Alopecia—Temozolomide—melanoma	0.00026	0.00101	CcSEcCtD
Alitretinoin—Dry skin—Docetaxel—melanoma	0.00026	0.00101	CcSEcCtD
Alitretinoin—Chest pain—Bleomycin—melanoma	0.000259	0.00101	CcSEcCtD
Alitretinoin—Myalgia—Bleomycin—melanoma	0.000259	0.00101	CcSEcCtD
Alitretinoin—Rash—Vemurafenib—melanoma	0.000258	0.001	CcSEcCtD
Alitretinoin—Mental disorder—Temozolomide—melanoma	0.000258	0.001	CcSEcCtD
Alitretinoin—Dermatitis—Vemurafenib—melanoma	0.000258	0.001	CcSEcCtD
Alitretinoin—Back pain—Carmustine—melanoma	0.000257	0.000997	CcSEcCtD
Alitretinoin—Headache—Vemurafenib—melanoma	0.000256	0.000997	CcSEcCtD
Alitretinoin—Erythema—Temozolomide—melanoma	0.000256	0.000996	CcSEcCtD
Alitretinoin—Malnutrition—Temozolomide—melanoma	0.000256	0.000996	CcSEcCtD
Alitretinoin—Discomfort—Bleomycin—melanoma	0.000256	0.000994	CcSEcCtD
Alitretinoin—Malaise—Dactinomycin—melanoma	0.000256	0.000994	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000255	0.000991	CcSEcCtD
Alitretinoin—Nasopharyngitis—Docetaxel—melanoma	0.000253	0.000984	CcSEcCtD
Alitretinoin—Confusional state—Bleomycin—melanoma	0.00025	0.000972	CcSEcCtD
Alitretinoin—Vision blurred—Carmustine—melanoma	0.00025	0.000972	CcSEcCtD
Alitretinoin—Tremor—Carmustine—melanoma	0.000249	0.000966	CcSEcCtD
Alitretinoin—Oedema—Bleomycin—melanoma	0.000248	0.000964	CcSEcCtD
Alitretinoin—Anaphylactic shock—Bleomycin—melanoma	0.000248	0.000964	CcSEcCtD
Alitretinoin—Back pain—Temozolomide—melanoma	0.000248	0.000964	CcSEcCtD
Alitretinoin—Infection—Bleomycin—melanoma	0.000246	0.000958	CcSEcCtD
Alitretinoin—Anaemia—Carmustine—melanoma	0.000245	0.000953	CcSEcCtD
Alitretinoin—Dysphagia—Docetaxel—melanoma	0.000245	0.000951	CcSEcCtD
Alitretinoin—Agitation—Carmustine—melanoma	0.000244	0.000948	CcSEcCtD
Alitretinoin—Nausea—Vemurafenib—melanoma	0.000243	0.000945	CcSEcCtD
Alitretinoin—Thrombocytopenia—Bleomycin—melanoma	0.000243	0.000944	CcSEcCtD
Alitretinoin—Vision blurred—Temozolomide—melanoma	0.000242	0.000939	CcSEcCtD
Alitretinoin—Myalgia—Dactinomycin—melanoma	0.000241	0.000938	CcSEcCtD
Alitretinoin—Bronchospasm—Docetaxel—melanoma	0.000241	0.000935	CcSEcCtD
Alitretinoin—Tremor—Temozolomide—melanoma	0.00024	0.000934	CcSEcCtD
Alitretinoin—Discomfort—Dactinomycin—melanoma	0.000238	0.000927	CcSEcCtD
Alitretinoin—Ill-defined disorder—Temozolomide—melanoma	0.000238	0.000925	CcSEcCtD
Alitretinoin—Anaemia—Temozolomide—melanoma	0.000237	0.000921	CcSEcCtD
Alitretinoin—Anorexia—Bleomycin—melanoma	0.000236	0.000919	CcSEcCtD
Alitretinoin—Agitation—Temozolomide—melanoma	0.000236	0.000916	CcSEcCtD
Alitretinoin—Hypotension—Bleomycin—melanoma	0.000232	0.000901	CcSEcCtD
Alitretinoin—Oedema—Dactinomycin—melanoma	0.000231	0.000899	CcSEcCtD
Alitretinoin—Malaise—Temozolomide—melanoma	0.000231	0.000899	CcSEcCtD
Alitretinoin—Convulsion—Carmustine—melanoma	0.00023	0.000893	CcSEcCtD
Alitretinoin—Infection—Dactinomycin—melanoma	0.00023	0.000893	CcSEcCtD
Alitretinoin—Hypertension—Carmustine—melanoma	0.000229	0.00089	CcSEcCtD
Alitretinoin—Neutropenia—Docetaxel—melanoma	0.000229	0.000889	CcSEcCtD
Alitretinoin—Palpitations—Temozolomide—melanoma	0.000227	0.000881	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dactinomycin—melanoma	0.000227	0.00088	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000226	0.000878	CcSEcCtD
Alitretinoin—Chest pain—Carmustine—melanoma	0.000226	0.000878	CcSEcCtD
Alitretinoin—Myalgia—Carmustine—melanoma	0.000226	0.000878	CcSEcCtD
Alitretinoin—Anxiety—Carmustine—melanoma	0.000225	0.000875	CcSEcCtD
Alitretinoin—Cough—Temozolomide—melanoma	0.000224	0.00087	CcSEcCtD
Alitretinoin—Paraesthesia—Bleomycin—melanoma	0.000223	0.000866	CcSEcCtD
Alitretinoin—Weight increased—Docetaxel—melanoma	0.000223	0.000866	CcSEcCtD
Alitretinoin—Convulsion—Temozolomide—melanoma	0.000222	0.000863	CcSEcCtD
Alitretinoin—Weight decreased—Docetaxel—melanoma	0.000221	0.00086	CcSEcCtD
Alitretinoin—Hypertension—Temozolomide—melanoma	0.000221	0.00086	CcSEcCtD
Alitretinoin—Dyspnoea—Bleomycin—melanoma	0.000221	0.00086	CcSEcCtD
Alitretinoin—Anorexia—Dactinomycin—melanoma	0.000221	0.000857	CcSEcCtD
Alitretinoin—Pneumonia—Docetaxel—melanoma	0.000219	0.000853	CcSEcCtD
Alitretinoin—Confusional state—Carmustine—melanoma	0.000218	0.000849	CcSEcCtD
Alitretinoin—Myalgia—Temozolomide—melanoma	0.000218	0.000848	CcSEcCtD
Alitretinoin—Arthralgia—Temozolomide—melanoma	0.000218	0.000848	CcSEcCtD
Alitretinoin—Infestation—Docetaxel—melanoma	0.000218	0.000848	CcSEcCtD
Alitretinoin—Infestation NOS—Docetaxel—melanoma	0.000218	0.000848	CcSEcCtD
Alitretinoin—Anxiety—Temozolomide—melanoma	0.000218	0.000845	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000217	0.000843	CcSEcCtD
Alitretinoin—Oedema—Carmustine—melanoma	0.000217	0.000842	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000216	0.000841	CcSEcCtD
Alitretinoin—Discomfort—Temozolomide—melanoma	0.000216	0.000838	CcSEcCtD
Alitretinoin—Decreased appetite—Bleomycin—melanoma	0.000216	0.000838	CcSEcCtD
Alitretinoin—Infection—Carmustine—melanoma	0.000215	0.000836	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Docetaxel—melanoma	0.000215	0.000836	CcSEcCtD
Alitretinoin—Renal failure—Docetaxel—melanoma	0.000214	0.000834	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Docetaxel—melanoma	0.000214	0.000831	CcSEcCtD
Alitretinoin—Myocardial infarction—Docetaxel—melanoma	0.000214	0.000831	CcSEcCtD
Alitretinoin—Dry mouth—Temozolomide—melanoma	0.000213	0.00083	CcSEcCtD
Alitretinoin—Stomatitis—Docetaxel—melanoma	0.000213	0.000827	CcSEcCtD
Alitretinoin—Pain—Bleomycin—melanoma	0.000212	0.000824	CcSEcCtD
Alitretinoin—Conjunctivitis—Docetaxel—melanoma	0.000212	0.000824	CcSEcCtD
Alitretinoin—Thrombocytopenia—Carmustine—melanoma	0.000212	0.000824	CcSEcCtD
Alitretinoin—Tachycardia—Carmustine—melanoma	0.000211	0.000821	CcSEcCtD
Alitretinoin—Confusional state—Temozolomide—melanoma	0.000211	0.00082	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000211	0.000819	CcSEcCtD
Alitretinoin—Oedema—Temozolomide—melanoma	0.000209	0.000813	CcSEcCtD
Alitretinoin—Anaphylactic shock—Temozolomide—melanoma	0.000209	0.000813	CcSEcCtD
Alitretinoin—Infection—Temozolomide—melanoma	0.000208	0.000808	CcSEcCtD
Alitretinoin—Anorexia—Carmustine—melanoma	0.000206	0.000802	CcSEcCtD
Alitretinoin—Epistaxis—Docetaxel—melanoma	0.000206	0.0008	CcSEcCtD
Alitretinoin—Nervous system disorder—Temozolomide—melanoma	0.000205	0.000798	CcSEcCtD
Alitretinoin—Thrombocytopenia—Temozolomide—melanoma	0.000205	0.000796	CcSEcCtD
Alitretinoin—Feeling abnormal—Bleomycin—melanoma	0.000204	0.000794	CcSEcCtD
Alitretinoin—Agranulocytosis—Docetaxel—melanoma	0.000204	0.000791	CcSEcCtD
Alitretinoin—Skin disorder—Temozolomide—melanoma	0.000203	0.00079	CcSEcCtD
Alitretinoin—Hypotension—Carmustine—melanoma	0.000202	0.000786	CcSEcCtD
Alitretinoin—Hyperhidrosis—Temozolomide—melanoma	0.000202	0.000786	CcSEcCtD
Alitretinoin—Decreased appetite—Dactinomycin—melanoma	0.000201	0.000782	CcSEcCtD
Alitretinoin—Fatigue—Dactinomycin—melanoma	0.000199	0.000775	CcSEcCtD
Alitretinoin—Anorexia—Temozolomide—melanoma	0.000199	0.000775	CcSEcCtD
Alitretinoin—Pain—Dactinomycin—melanoma	0.000198	0.000769	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Carmustine—melanoma	0.000197	0.000767	CcSEcCtD
Alitretinoin—Urticaria—Bleomycin—melanoma	0.000197	0.000766	CcSEcCtD
Alitretinoin—Haemoglobin—Docetaxel—melanoma	0.000197	0.000765	CcSEcCtD
Alitretinoin—Body temperature increased—Bleomycin—melanoma	0.000196	0.000762	CcSEcCtD
Alitretinoin—Haemorrhage—Docetaxel—melanoma	0.000196	0.000761	CcSEcCtD
Alitretinoin—Hepatitis—Docetaxel—melanoma	0.000196	0.000761	CcSEcCtD
Alitretinoin—Insomnia—Carmustine—melanoma	0.000196	0.000761	CcSEcCtD
Alitretinoin—Hypoaesthesia—Docetaxel—melanoma	0.000195	0.000757	CcSEcCtD
Alitretinoin—Paraesthesia—Carmustine—melanoma	0.000194	0.000756	CcSEcCtD
Alitretinoin—Pharyngitis—Docetaxel—melanoma	0.000194	0.000756	CcSEcCtD
Alitretinoin—Urinary tract disorder—Docetaxel—melanoma	0.000193	0.000752	CcSEcCtD
Alitretinoin—Dyspnoea—Carmustine—melanoma	0.000193	0.00075	CcSEcCtD
Alitretinoin—Oedema peripheral—Docetaxel—melanoma	0.000193	0.00075	CcSEcCtD
Alitretinoin—Somnolence—Carmustine—melanoma	0.000192	0.000748	CcSEcCtD
Alitretinoin—Urethral disorder—Docetaxel—melanoma	0.000192	0.000746	CcSEcCtD
Alitretinoin—Feeling abnormal—Dactinomycin—melanoma	0.000191	0.000741	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000191	0.000741	CcSEcCtD
Alitretinoin—Insomnia—Temozolomide—melanoma	0.000189	0.000736	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dactinomycin—melanoma	0.000189	0.000735	CcSEcCtD
Alitretinoin—Visual impairment—Docetaxel—melanoma	0.000189	0.000734	CcSEcCtD
Alitretinoin—Decreased appetite—Carmustine—melanoma	0.000188	0.000732	CcSEcCtD
Alitretinoin—Paraesthesia—Temozolomide—melanoma	0.000188	0.00073	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Carmustine—melanoma	0.000187	0.000727	CcSEcCtD
Alitretinoin—Dyspnoea—Temozolomide—melanoma	0.000187	0.000725	CcSEcCtD
Alitretinoin—Somnolence—Temozolomide—melanoma	0.000186	0.000723	CcSEcCtD
Alitretinoin—Erythema multiforme—Docetaxel—melanoma	0.000185	0.00072	CcSEcCtD
Alitretinoin—Pain—Carmustine—melanoma	0.000185	0.00072	CcSEcCtD
Alitretinoin—Constipation—Carmustine—melanoma	0.000185	0.00072	CcSEcCtD
Alitretinoin—Dyspepsia—Temozolomide—melanoma	0.000184	0.000716	CcSEcCtD
Alitretinoin—Eye disorder—Docetaxel—melanoma	0.000183	0.000711	CcSEcCtD
Alitretinoin—Body temperature increased—Dactinomycin—melanoma	0.000183	0.000711	CcSEcCtD
Alitretinoin—Abdominal pain—Dactinomycin—melanoma	0.000183	0.000711	CcSEcCtD
Alitretinoin—Hypersensitivity—Bleomycin—melanoma	0.000183	0.00071	CcSEcCtD
Alitretinoin—ABCB1—lymph node—melanoma	0.000182	0.00243	CbGeAlD
Alitretinoin—Decreased appetite—Temozolomide—melanoma	0.000182	0.000707	CcSEcCtD
Alitretinoin—Flushing—Docetaxel—melanoma	0.000182	0.000706	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Temozolomide—melanoma	0.000181	0.000702	CcSEcCtD
Alitretinoin—Fatigue—Temozolomide—melanoma	0.00018	0.000701	CcSEcCtD
Alitretinoin—Pain—Temozolomide—melanoma	0.000179	0.000695	CcSEcCtD
Alitretinoin—Constipation—Temozolomide—melanoma	0.000179	0.000695	CcSEcCtD
Alitretinoin—Feeling abnormal—Carmustine—melanoma	0.000178	0.000693	CcSEcCtD
Alitretinoin—Asthenia—Bleomycin—melanoma	0.000178	0.000692	CcSEcCtD
Alitretinoin—Angiopathy—Docetaxel—melanoma	0.000178	0.000691	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Carmustine—melanoma	0.000177	0.000688	CcSEcCtD
Alitretinoin—Chills—Docetaxel—melanoma	0.000176	0.000683	CcSEcCtD
Alitretinoin—Pruritus—Bleomycin—melanoma	0.000176	0.000682	CcSEcCtD
Alitretinoin—Arrhythmia—Docetaxel—melanoma	0.000175	0.00068	CcSEcCtD
Alitretinoin—Alopecia—Docetaxel—melanoma	0.000173	0.000673	CcSEcCtD
Alitretinoin—Feeling abnormal—Temozolomide—melanoma	0.000172	0.00067	CcSEcCtD
Alitretinoin—Mental disorder—Docetaxel—melanoma	0.000172	0.000667	CcSEcCtD
Alitretinoin—Body temperature increased—Carmustine—melanoma	0.000171	0.000665	CcSEcCtD
Alitretinoin—Abdominal pain—Carmustine—melanoma	0.000171	0.000665	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Temozolomide—melanoma	0.000171	0.000665	CcSEcCtD
Alitretinoin—Malnutrition—Docetaxel—melanoma	0.000171	0.000663	CcSEcCtD
Alitretinoin—Erythema—Docetaxel—melanoma	0.000171	0.000663	CcSEcCtD
Alitretinoin—Hypersensitivity—Dactinomycin—melanoma	0.00017	0.000662	CcSEcCtD
Alitretinoin—Urticaria—Temozolomide—melanoma	0.000166	0.000646	CcSEcCtD
Alitretinoin—Asthenia—Dactinomycin—melanoma	0.000166	0.000645	CcSEcCtD
Alitretinoin—Abdominal pain—Temozolomide—melanoma	0.000165	0.000643	CcSEcCtD
Alitretinoin—Body temperature increased—Temozolomide—melanoma	0.000165	0.000643	CcSEcCtD
Alitretinoin—Back pain—Docetaxel—melanoma	0.000165	0.000641	CcSEcCtD
Alitretinoin—Hypersensitivity—Carmustine—melanoma	0.00016	0.00062	CcSEcCtD
Alitretinoin—Diarrhoea—Dactinomycin—melanoma	0.000158	0.000615	CcSEcCtD
Alitretinoin—Vomiting—Bleomycin—melanoma	0.000158	0.000613	CcSEcCtD
Alitretinoin—Anaemia—Docetaxel—melanoma	0.000158	0.000612	CcSEcCtD
Alitretinoin—Rash—Bleomycin—melanoma	0.000156	0.000608	CcSEcCtD
Alitretinoin—Dermatitis—Bleomycin—melanoma	0.000156	0.000607	CcSEcCtD
Alitretinoin—Asthenia—Carmustine—melanoma	0.000155	0.000604	CcSEcCtD
Alitretinoin—Hypersensitivity—Temozolomide—melanoma	0.000154	0.000599	CcSEcCtD
Alitretinoin—Syncope—Docetaxel—melanoma	0.000153	0.000594	CcSEcCtD
Alitretinoin—Palpitations—Docetaxel—melanoma	0.000151	0.000586	CcSEcCtD
Alitretinoin—Asthenia—Temozolomide—melanoma	0.00015	0.000583	CcSEcCtD
Alitretinoin—Loss of consciousness—Docetaxel—melanoma	0.00015	0.000582	CcSEcCtD
Alitretinoin—Cough—Docetaxel—melanoma	0.000149	0.000578	CcSEcCtD
Alitretinoin—Diarrhoea—Carmustine—melanoma	0.000148	0.000576	CcSEcCtD
Alitretinoin—Pruritus—Temozolomide—melanoma	0.000148	0.000575	CcSEcCtD
Alitretinoin—Convulsion—Docetaxel—melanoma	0.000148	0.000574	CcSEcCtD
Alitretinoin—Nausea—Bleomycin—melanoma	0.000147	0.000573	CcSEcCtD
Alitretinoin—Hypertension—Docetaxel—melanoma	0.000147	0.000572	CcSEcCtD
Alitretinoin—Vomiting—Dactinomycin—melanoma	0.000147	0.000572	CcSEcCtD
Alitretinoin—Rash—Dactinomycin—melanoma	0.000146	0.000567	CcSEcCtD
Alitretinoin—Arthralgia—Docetaxel—melanoma	0.000145	0.000564	CcSEcCtD
Alitretinoin—Chest pain—Docetaxel—melanoma	0.000145	0.000564	CcSEcCtD
Alitretinoin—Myalgia—Docetaxel—melanoma	0.000145	0.000564	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000144	0.00056	CcSEcCtD
Alitretinoin—Dizziness—Carmustine—melanoma	0.000143	0.000556	CcSEcCtD
Alitretinoin—Diarrhoea—Temozolomide—melanoma	0.000143	0.000556	CcSEcCtD
Alitretinoin—Dry mouth—Docetaxel—melanoma	0.000142	0.000552	CcSEcCtD
Alitretinoin—Confusional state—Docetaxel—melanoma	0.00014	0.000545	CcSEcCtD
Alitretinoin—Oedema—Docetaxel—melanoma	0.000139	0.000541	CcSEcCtD
Alitretinoin—Anaphylactic shock—Docetaxel—melanoma	0.000139	0.000541	CcSEcCtD
Alitretinoin—Dizziness—Temozolomide—melanoma	0.000138	0.000538	CcSEcCtD
Alitretinoin—Infection—Docetaxel—melanoma	0.000138	0.000537	CcSEcCtD
Alitretinoin—Vomiting—Carmustine—melanoma	0.000138	0.000535	CcSEcCtD
Alitretinoin—Nausea—Dactinomycin—melanoma	0.000137	0.000534	CcSEcCtD
Alitretinoin—Shock—Docetaxel—melanoma	0.000137	0.000532	CcSEcCtD
Alitretinoin—Rash—Carmustine—melanoma	0.000137	0.000531	CcSEcCtD
Alitretinoin—Nervous system disorder—Docetaxel—melanoma	0.000136	0.00053	CcSEcCtD
Alitretinoin—Dermatitis—Carmustine—melanoma	0.000136	0.00053	CcSEcCtD
Alitretinoin—Thrombocytopenia—Docetaxel—melanoma	0.000136	0.00053	CcSEcCtD
Alitretinoin—Tachycardia—Docetaxel—melanoma	0.000136	0.000528	CcSEcCtD
Alitretinoin—Headache—Carmustine—melanoma	0.000136	0.000527	CcSEcCtD
Alitretinoin—Skin disorder—Docetaxel—melanoma	0.000135	0.000525	CcSEcCtD
Alitretinoin—Vomiting—Temozolomide—melanoma	0.000133	0.000517	CcSEcCtD
Alitretinoin—Anorexia—Docetaxel—melanoma	0.000133	0.000516	CcSEcCtD
Alitretinoin—Rash—Temozolomide—melanoma	0.000132	0.000513	CcSEcCtD
Alitretinoin—Dermatitis—Temozolomide—melanoma	0.000132	0.000512	CcSEcCtD
Alitretinoin—Headache—Temozolomide—melanoma	0.000131	0.000509	CcSEcCtD
Alitretinoin—Hypotension—Docetaxel—melanoma	0.00013	0.000505	CcSEcCtD
Alitretinoin—Nausea—Carmustine—melanoma	0.000129	0.0005	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000127	0.000493	CcSEcCtD
Alitretinoin—Insomnia—Docetaxel—melanoma	0.000126	0.000489	CcSEcCtD
Alitretinoin—Paraesthesia—Docetaxel—melanoma	0.000125	0.000486	CcSEcCtD
Alitretinoin—Nausea—Temozolomide—melanoma	0.000124	0.000483	CcSEcCtD
Alitretinoin—Dyspnoea—Docetaxel—melanoma	0.000124	0.000482	CcSEcCtD
Alitretinoin—Somnolence—Docetaxel—melanoma	0.000124	0.000481	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—melanoma	0.000122	0.000476	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—melanoma	0.000121	0.00047	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—melanoma	0.00012	0.000467	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—melanoma	0.00012	0.000466	CcSEcCtD
Alitretinoin—Pain—Docetaxel—melanoma	0.000119	0.000462	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—melanoma	0.000119	0.000462	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—melanoma	0.000115	0.000446	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—melanoma	0.000114	0.000442	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—melanoma	0.00011	0.000428	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—melanoma	0.00011	0.000428	CcSEcCtD
Alitretinoin—Hypersensitivity—Docetaxel—melanoma	0.000103	0.000398	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—melanoma	9.98e-05	0.000388	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—melanoma	9.85e-05	0.000383	CcSEcCtD
Alitretinoin—Diarrhoea—Docetaxel—melanoma	9.52e-05	0.00037	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—melanoma	9.2e-05	0.000358	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—melanoma	8.85e-05	0.000344	CcSEcCtD
Alitretinoin—Rash—Docetaxel—melanoma	8.77e-05	0.000341	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—melanoma	8.77e-05	0.000341	CcSEcCtD
Alitretinoin—Headache—Docetaxel—melanoma	8.72e-05	0.000339	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—melanoma	8.27e-05	0.000321	CcSEcCtD
Alitretinoin—RARG—Gene Expression—NOTCH1—melanoma	3.91e-05	0.000208	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CD—melanoma	3.87e-05	0.000206	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CD—melanoma	3.87e-05	0.000206	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.86e-05	0.000205	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.86e-05	0.000205	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	3.84e-05	0.000205	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	3.84e-05	0.000204	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	3.84e-05	0.000204	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—melanoma	3.82e-05	0.000203	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—melanoma	3.82e-05	0.000203	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.81e-05	0.000203	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.8e-05	0.000202	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—melanoma	3.76e-05	0.0002	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—melanoma	3.76e-05	0.0002	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	3.73e-05	0.000199	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	3.69e-05	0.000197	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—melanoma	3.69e-05	0.000196	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.67e-05	0.000195	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	3.66e-05	0.000195	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	3.66e-05	0.000195	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	3.66e-05	0.000195	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.64e-05	0.000194	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH1—melanoma	3.64e-05	0.000194	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—melanoma	3.64e-05	0.000194	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	3.63e-05	0.000193	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	3.59e-05	0.000191	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH1—melanoma	3.58e-05	0.00019	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CDK4—melanoma	3.56e-05	0.000189	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MET—melanoma	3.56e-05	0.000189	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	3.52e-05	0.000187	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G6—melanoma	3.52e-05	0.000187	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NOTCH1—melanoma	3.51e-05	0.000187	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACER3—melanoma	3.5e-05	0.000186	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—melanoma	3.47e-05	0.000185	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	3.46e-05	0.000184	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—melanoma	3.44e-05	0.000183	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NOTCH1—melanoma	3.43e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	3.39e-05	0.00018	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—melanoma	3.38e-05	0.00018	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CB—melanoma	3.37e-05	0.000179	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CB—melanoma	3.37e-05	0.000179	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH1—melanoma	3.36e-05	0.000179	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH1—melanoma	3.36e-05	0.000179	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.35e-05	0.000178	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—melanoma	3.34e-05	0.000178	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—melanoma	3.34e-05	0.000178	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—melanoma	3.31e-05	0.000176	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.24e-05	0.000172	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—melanoma	3.23e-05	0.000172	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	3.22e-05	0.000171	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UGT2B10—melanoma	3.2e-05	0.00017	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—melanoma	3.17e-05	0.000169	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—melanoma	3.17e-05	0.000169	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.17e-05	0.000169	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—VCAN—melanoma	3.16e-05	0.000168	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	3.09e-05	0.000164	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.06e-05	0.000163	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HDAC2—melanoma	3.05e-05	0.000162	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.04e-05	0.000162	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.99e-05	0.000159	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—melanoma	2.97e-05	0.000158	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HS3ST5—melanoma	2.97e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—melanoma	2.97e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAP2K1—melanoma	2.96e-05	0.000158	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.96e-05	0.000158	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—melanoma	2.91e-05	0.000155	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—melanoma	2.91e-05	0.000155	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.89e-05	0.000154	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.86e-05	0.000152	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.83e-05	0.000151	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—FGF2—melanoma	2.82e-05	0.00015	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACER3—melanoma	2.79e-05	0.000149	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.73e-05	0.000145	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.67e-05	0.000142	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP17A1—melanoma	2.67e-05	0.000142	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.63e-05	0.00014	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.62e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—melanoma	2.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—melanoma	2.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.56e-05	0.000136	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UGT2B10—melanoma	2.55e-05	0.000136	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.53e-05	0.000135	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.52e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GNA11—melanoma	2.52e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—melanoma	2.47e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—FASN—melanoma	2.46e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CDKN2B—melanoma	2.43e-05	0.000129	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC5A5—melanoma	2.42e-05	0.000129	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.41e-05	0.000128	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HS3ST5—melanoma	2.37e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—melanoma	2.37e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GNAQ—melanoma	2.34e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD44—melanoma	2.34e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.29e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.29e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—melanoma	2.28e-05	0.000121	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.27e-05	0.000121	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.26e-05	0.00012	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLCB4—melanoma	2.25e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1B1—melanoma	2.24e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—melanoma	2.23e-05	0.000119	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.22e-05	0.000118	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—melanoma	2.21e-05	0.000117	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PRKCA—melanoma	2.19e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.17e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ERCC2—melanoma	2.17e-05	0.000115	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—melanoma	2.16e-05	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC6A11—melanoma	2.12e-05	0.000113	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIP4K2A—melanoma	2.12e-05	0.000113	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—melanoma	2.1e-05	0.000112	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.07e-05	0.00011	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTAP—melanoma	2.06e-05	0.00011	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.06e-05	0.00011	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—melanoma	2.06e-05	0.000109	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—melanoma	2.06e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.02e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—melanoma	2e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—melanoma	1.98e-05	0.000106	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.98e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NRAS—melanoma	1.98e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—melanoma	1.98e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.96e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—melanoma	1.96e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.95e-05	0.000104	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—melanoma	1.94e-05	0.000103	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—melanoma	1.92e-05	0.000102	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.91e-05	0.000102	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.9e-05	0.000101	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.9e-05	0.000101	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—melanoma	1.9e-05	0.000101	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—melanoma	1.89e-05	0.0001	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.89e-05	0.0001	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—melanoma	1.86e-05	9.9e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—melanoma	1.86e-05	9.9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—melanoma	1.85e-05	9.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LUM—melanoma	1.84e-05	9.78e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PHGDH—melanoma	1.84e-05	9.78e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—melanoma	1.81e-05	9.63e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—melanoma	1.81e-05	9.63e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK1—melanoma	1.8e-05	9.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—melanoma	1.8e-05	9.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPSE—melanoma	1.8e-05	9.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLCB4—melanoma	1.8e-05	9.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CUBN—melanoma	1.77e-05	9.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.77e-05	9.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—melanoma	1.75e-05	9.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—melanoma	1.72e-05	9.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.71e-05	9.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SDHD—melanoma	1.71e-05	9.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BSG—melanoma	1.71e-05	9.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CSPG4—melanoma	1.71e-05	9.09e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—melanoma	1.7e-05	9.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PRKCA—melanoma	1.7e-05	9.05e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC6A11—melanoma	1.69e-05	9e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIP4K2A—melanoma	1.69e-05	9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ERCC2—melanoma	1.69e-05	8.98e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—melanoma	1.68e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—melanoma	1.68e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—melanoma	1.65e-05	8.8e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPAM—melanoma	1.65e-05	8.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTAP—melanoma	1.65e-05	8.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.62e-05	8.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.61e-05	8.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.58e-05	8.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.54e-05	8.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.54e-05	8.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.47e-05	7.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PHGDH—melanoma	1.47e-05	7.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LUM—melanoma	1.47e-05	7.8e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—melanoma	1.46e-05	7.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.46e-05	7.75e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—melanoma	1.45e-05	7.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPSE—melanoma	1.44e-05	7.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CUBN—melanoma	1.41e-05	7.51e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G6—melanoma	1.41e-05	7.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.4e-05	7.44e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—melanoma	1.39e-05	7.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BSG—melanoma	1.36e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CSPG4—melanoma	1.36e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SDHD—melanoma	1.36e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.34e-05	7.12e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—melanoma	1.33e-05	7.1e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—melanoma	1.33e-05	7.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPAM—melanoma	1.32e-05	7.03e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—melanoma	1.31e-05	6.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.29e-05	6.89e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—melanoma	1.29e-05	6.84e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—melanoma	1.28e-05	6.8e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—VCAN—melanoma	1.26e-05	6.72e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—melanoma	1.25e-05	6.68e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—melanoma	1.25e-05	6.68e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—melanoma	1.17e-05	6.23e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—melanoma	1.16e-05	6.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G6—melanoma	1.12e-05	5.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.09e-05	5.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP17A1—melanoma	1.07e-05	5.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—melanoma	1.02e-05	5.43e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—melanoma	1.01e-05	5.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—VCAN—melanoma	1.01e-05	5.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GNA11—melanoma	1.01e-05	5.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.87e-06	5.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FASN—melanoma	9.85e-06	5.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—melanoma	9.7e-06	5.16e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—melanoma	9.69e-06	5.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.55e-06	5.08e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—melanoma	9.43e-06	5.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GNAQ—melanoma	9.36e-06	4.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD44—melanoma	9.36e-06	4.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.21e-06	4.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1B1—melanoma	8.97e-06	4.77e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—melanoma	8.82e-06	4.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP17A1—melanoma	8.51e-06	4.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.39e-06	4.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.28e-06	4.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GNA11—melanoma	8.04e-06	4.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FASN—melanoma	7.86e-06	4.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—melanoma	7.73e-06	4.12e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GNAQ—melanoma	7.47e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD44—melanoma	7.47e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.31e-06	3.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.25e-06	3.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1B1—melanoma	7.16e-06	3.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PRKCA—melanoma	6.8e-06	3.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ERCC2—melanoma	6.74e-06	3.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—melanoma	6.54e-06	3.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.32e-06	3.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—melanoma	6.22e-06	3.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—melanoma	5.9e-06	3.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PRKCA—melanoma	5.43e-06	2.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ERCC2—melanoma	5.38e-06	2.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—melanoma	5.33e-06	2.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—melanoma	5.14e-06	2.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—melanoma	5.09e-06	2.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—melanoma	4.68e-06	2.49e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—melanoma	4.62e-06	2.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.46e-06	2.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—melanoma	4.25e-06	2.26e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—melanoma	4.1e-06	2.18e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—melanoma	4.08e-06	2.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—melanoma	4.04e-06	2.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—melanoma	3.74e-06	1.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—melanoma	3.69e-06	1.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—melanoma	3.53e-06	1.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—melanoma	3.26e-06	1.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—melanoma	3.23e-06	1.72e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—melanoma	2.81e-06	1.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—melanoma	2.49e-06	1.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—melanoma	2.03e-06	1.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—melanoma	1.99e-06	1.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—melanoma	1.62e-06	8.63e-06	CbGpPWpGaD
